التفاصيل البيبلوغرافية
العنوان: |
Baseline predictors of microalbuminuria development at univariable and multivariable analyses. |
المؤلفون: |
Piero Ruggenenti (180711), Monica Cortinovis (5399138), Aneliya Parvanova (11133325), Matias Trillini (6560225), Ilian P. Iliev (11133328), Antonio C. Bossi (9452934), Antonio Belviso (11133331), Maria C. Aparicio (11133334), Roberto Trevisan (499060), Stefano Rota (3834721), Annalisa Perna (6560222), Tobia Peracchi (11133337), Nadia Rubis (6560240), Davide Martinetti (10823998), Silvia Prandini (180731), Flavio Gaspari (180714), Fabiola Carrara (180719), Salvatore De Cosmo (158567), Giancarlo Tonolo (256228), Ruggero Mangili (11133340), Giuseppe Remuzzi (180748) |
سنة النشر: |
2021 |
المجموعة: |
Smithsonian Institution: Digital Repository |
مصطلحات موضوعية: |
Medicine, Physiology, Pharmacology, Biotechnology, Marine Biology, Cancer, Infectious Diseases, Virology, microalbuminuria, RAS, BP, ACE, acceleration factors, 612 type 2, combination therapy, benazepril, VARIETY, valsartan, normoalbuminuric type 2, failure time model, Istituto di Ricerche Farmacologiche., angiotensin receptor blockers, CI, combination therapy group, study Background Angiotensin, mg, PROBE, IQR, ClinicalTrials.gov NCT 00503152, Trial registration EudraCT 2006-005. |
الوصف: |
(DOCX) |
نوع الوثيقة: |
article in journal/newspaper |
اللغة: |
unknown |
Relation: |
https://figshare.com/articles/journal_contribution/Baseline_predictors_of_microalbuminuria_development_at_univariable_and_multivariable_analyses_/14981701 |
DOI: |
10.1371/journal.pmed.1003691.s002 |
الاتاحة: |
https://doi.org/10.1371/journal.pmed.1003691.s002 |
Rights: |
CC BY 4.0 |
رقم الانضمام: |
edsbas.85D4FD2A |
قاعدة البيانات: |
BASE |